Ammar Almaaytah
Overview
Explore the profile of Ammar Almaaytah including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
357
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Darwish R, Almaaytah A, Salama A
Res Pharm Sci
. 2023 Jan;
17(6):612-620.
PMID: 36704429
Background And Purpose: Antimicrobial resistance still constitutes a major health concern to the global human population. The development of new classes of antimicrobial agents is urgently needed to thwart the...
2.
Salama A, Almaaytah A, Darwish R
Antibiotics (Basel)
. 2021 Jul;
10(6).
PMID: 34199154
(1) Background: Antimicrobial resistance represents an urgent health dilemma facing the global human population. The development of novel antimicrobial agents is needed to face the rising number of resistant bacteria....
3.
Almaaytah A
Clinicoecon Outcomes Res
. 2020 Sep;
12:527-534.
PMID: 32982342
Introduction: Biosimilars of monoclonal antibodies are being rapidly developed and approved by public health regulatory authorities worldwide. These biosimilars are expected to bring significant budgetary savings to national governments and...
4.
Al Tall Y, Al-Rawashdeh B, Abualhaijaa A, Almaaytah A, Masadeh M, Alzoubi K
Curr Pharm Des
. 2020 Feb;
26(3):376-385.
PMID: 32003660
Background: Multi-drug resistant infections are a growing worldwide health concern. There is an urgent need to produce alternative antimicrobial agents. Objective: The study aimed to design a new hybrid antimicrobial...
5.
Swedan S, Shubair Z, Almaaytah A
Infect Drug Resist
. 2019 Aug;
12:2019-2030.
PMID: 31372010
Purpose: The activity of the cationic antimicrobial peptide WLBU2 was evaluated against planktonic cells and biofilms of multi-drug resistant (MDR) and , alone and in combination with classical antimicrobial agents....
6.
Almaaytah A, Abualhaijaa A, Alqudah O
Infect Drug Resist
. 2019 Jun;
12:1371-1380.
PMID: 31213855
Antimicrobial resistance toward antibiotics is reaching historical unprecedented levels. There is an urgent and imminent need to develop novel antimicrobial alternatives. Antimicrobial peptides could prove to be a successful group...
7.
Al Tall Y, Abualhaijaa A, Alsaggar M, Almaaytah A, Masadeh M, Alzoubi K
Infect Drug Resist
. 2019 May;
12:1035-1045.
PMID: 31118709
The world is heading to a post-antibiotic era where the treatment of bacterial infections will not be possible even with well-known last-line antibiotics. Unfortunately, the emergence of multidrug resistant bacterial...
8.
Almaaytah A, Albalas Q, Alzoubi K
Infect Drug Resist
. 2018 Sep;
11:1383-1386.
PMID: 30214259
Background: The consistent upsurge in antimicrobial resistance globally is threatening the world population with the prospect of facing the post-antibiotic era. Dry pipelines and a drastic decrease of antimicrobial drug...
9.
Almaaytah A, Farajallah A, Abualhaijaa A, Al-Balas Q
Molecules
. 2018 Jul;
23(7).
PMID: 30004427
Current research in the field of antimicrobials is focused on developing novel antimicrobial agents to counteract the huge dilemma that the human population is mainly facing in regards to the...
10.
Almaaytah A, Qaoud M, Abualhaijaa A, Al-Balas Q, Alzoubi K
Infect Drug Resist
. 2018 Jun;
11:835-847.
PMID: 29910626
Introduction: As the development of new antimicrobial agents faces a historical decline, the issue of bacterial drug resistance has become a serious dilemma that threatens the human population worldwide. Antimicrobial...